The Indian corporate healthcare sector is poised for robust growth over the next two fiscal years, with projections indicating a 15% year-on-year (YoY) increase in sales revenue for FY25-FY26. This growth is primarily being driven by higher Average Revenue per Occupied Bed (ARPOB), expanded bed capacity, and an overall improvement in the efficiency of healthcare services, according to a recent report by India Ratings and Research (Ind-Ra).
Key Growth Drivers
Several factors are converging to fuel growth in the corporate healthcare sector:
1. Growth in ARPOB: The ARPOB is anticipated to see a steady increase of 5-6%. This reflects a natural rise in service pricing and utilization, moving closer to aligning Indian hospital standards with global benchmarks.
2. Increase in Bed Capacity: Corporate hospitals are gearing up to add 6-8% more beds in the coming fiscal years to match rising demand. This structural readiness is expected to help cater to an expanding patient base effectively.
3. Higher Occupancy Rates: A 100-200 bps improvement in occupancy rates will further boost the bottom-line performance of hospitals, particularly in urban areas.
Sustained Demand and Opportunity
The healthcare sector has witnessed accelerated demand for quality medical services in recent years, a trend that continues in FY26. The COVID-19 pandemic underscored the critical need for resilient healthcare infrastructure, pushing private players to scale up and innovate.
Key areas of growth, including acquisitions of smaller hospitals by larger chains, are enhancing economies of scale, giving larger players a competitive edge. Director of Corporate Ratings at Ind-Ra, Vivek Jain, highlighted that such acquisitions strengthen financial structures while creating significant growth opportunities.
Improved Profitability despite Expansion Costs
Even amid aggressive capacity expansion and the accompanying rise in overhead costs, the sector’s EBITDA margins are projected to remain healthy. EBITDA margins are expected to rise to 20.9% in FY26 compared to 20% in FY25. Such steadiness reflects improved operational efficiencies and sustained demand.
Capital expenditure for enhancing infrastructure and facilities has been planned in a calibrated manner to maintain liquidity. Though companies in the sector are expected to take on additional debt to fund expansions, strong operating profits are projected to balance out leverage ratios, ensuring a stable credit profile for major players.
Indian Healthcare Sector’s Growth Outlook
The report indicates tremendous opportunities for growth in the near to medium term, driven by the modernization of healthcare facilities and better delivery standards. Additionally, the pharmaceutical sector in India is expected to grow by 9-10% YoY in FY26. With increasing demand in domestic chronic care segments and growth in U.S.-based generics, along with contract development and manufacturing services, pharmaceutical companies remain a stable contributor to the healthcare ecosystem.
Challenges and Opportunities Ahead
Despite the promising outlook, certain challenges remain for the sector, including regulatory hurdles, workforce shortages, and the need for technology adoption. However, the increased focus on healthcare infrastructure by both private entities and the government is a positive indicator for overcoming these challenges.
Overall, India’s corporate healthcare sector is well-positioned to capitalize on the rising demand for quality medical services. With strong fundamentals and strategic planning for expansion, the sector is heading toward a phase of significant contribution to the nation’s economic growth. By sustaining profitability and focusing on infrastructure development, corporate healthcare players are set to play a critical role in meeting India’s evolving healthcare needs.
-Raja Aditya




